Lantern Pharma Inc (LTRN)
6.06
-0.24
(-3.81%)
USD |
NASDAQ |
May 31, 16:00
6.10
+0.04
(+0.66%)
After-Hours: 20:00
Lantern Pharma Free Cash Flow: -13.67M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -13.67M |
December 31, 2023 | -14.37M |
September 30, 2023 | -13.65M |
June 30, 2023 | -14.08M |
March 31, 2023 | -13.23M |
December 31, 2022 | -12.80M |
September 30, 2022 | -12.16M |
June 30, 2022 | -12.80M |
March 31, 2022 | -11.79M |
Date | Value |
---|---|
December 31, 2021 | -10.61M |
September 30, 2021 | -10.14M |
June 30, 2021 | -8.348M |
March 31, 2021 | -7.109M |
December 31, 2020 | -5.668M |
September 30, 2020 | -4.804M |
June 30, 2020 | -2.466M |
March 31, 2020 | -2.405M |
December 31, 2019 | -2.128M |
Free Cash Flow Range, Past 5 Years
-14.37M
Minimum
Dec 2023
-2.128M
Maximum
Dec 2019
-9.568M
Average
-11.20M
Median
Free Cash Flow Benchmarks
Eyenovia Inc | -29.93M |
Cassava Sciences Inc | -87.90M |
Alpine Immune Sciences Inc (DELISTED) | -80.96M |
Clearside Biomedical Inc | -20.49M |
Poseida Therapeutics Inc | -71.71M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -3.068M |
Cash from Investing (Quarterly) | -0.5562M |
Cash from Financing (Quarterly) | 0.0547M |
Free Cash Flow Per Share (Quarterly) | -0.2858 |
Free Cash Flow Yield | -20.86% |